← Chewy overview
Chewy IncCHWY

Why is Chewy (CHWY) moving?

Q3 2026
▲2▼2

Chewy's growth slows, AI savings rise, but Wall Street turns cautious

  • Chewy cuts 2026 growth outlook Chewy lowered its 2026 growth expectations, signaling weaker demand for pet products. This makes future sales look softer and pushes the stock down because investors pay for growth.

    This is the first sign of slowing demand and sets a cautious tone for the period.

  • AI cost savings target raised to $50M Chewy said AI will save $50 million a year by fiscal 2027, up from earlier plans. Lower costs mean higher profits without needing more sales, which supports the stock price.

    This is a new, concrete profit driver that offsets some demand worries.

  • Q2 revenue up 7.3%, vet care and fresh food boom Chewy's second-quarter revenue rose 7.3%, with triple-digit growth in vet clinics and fresh/frozen food. Autoship subscriptions hit 84.6% of sales, showing loyal customers. This beat expectations and points to steady demand.

    This is the key earnings report that shows the business is still growing despite a tough pet market.

  • JPMorgan downgrade and tariff-benefit concerns JPMorgan cut Chewy to Neutral and lowered its price target to $24, warning that a one-time tariff benefit may have flattered earnings. The stock fell 11% as investors worried the profit beat wasn't sustainable.

    This is the latest analyst reaction that explains why the stock dropped even after good results.

August 2026
▲2▼2

Chewy's growth slows, AI savings rise, but Wall Street turns cautious

  • Chewy cuts 2026 growth outlook Chewy lowered its 2026 growth expectations, signaling weaker demand for pet products. This makes future sales look softer and pushes the stock down because investors pay for growth.

    This is the first sign of slowing demand and sets a cautious tone for the period.

  • AI cost savings target raised to $50M Chewy said AI will save $50 million a year by fiscal 2027, up from earlier plans. Lower costs mean higher profits without needing more sales, which supports the stock price.

    This is a new, concrete profit driver that offsets some demand worries.

  • Q2 revenue up 7.3%, vet care and fresh food boom Chewy's second-quarter revenue rose 7.3%, with triple-digit growth in vet clinics and fresh/frozen food. Autoship subscriptions hit 84.6% of sales, showing loyal customers. This beat expectations and points to steady demand.

    This is the key earnings report that shows the business is still growing despite a tough pet market.

  • JPMorgan downgrade and tariff-benefit concerns JPMorgan cut Chewy to Neutral and lowered its price target to $24, warning that a one-time tariff benefit may have flattered earnings. The stock fell 11% as investors worried the profit beat wasn't sustainable.

    This is the latest analyst reaction that explains why the stock dropped even after good results.

Latest
▲2▼2

Chewy's growth slows, AI savings rise, but Wall Street turns cautious

  • Chewy cuts 2026 growth outlook Chewy lowered its 2026 growth expectations, signaling weaker demand for pet products. This makes future sales look softer and pushes the stock down because investors pay for growth.

    This is the first sign of slowing demand and sets a cautious tone for the period.

  • AI cost savings target raised to $50M Chewy said AI will save $50 million a year by fiscal 2027, up from earlier plans. Lower costs mean higher profits without needing more sales, which supports the stock price.

    This is a new, concrete profit driver that offsets some demand worries.

  • Q2 revenue up 7.3%, vet care and fresh food boom Chewy's second-quarter revenue rose 7.3%, with triple-digit growth in vet clinics and fresh/frozen food. Autoship subscriptions hit 84.6% of sales, showing loyal customers. This beat expectations and points to steady demand.

    This is the key earnings report that shows the business is still growing despite a tough pet market.

  • JPMorgan downgrade and tariff-benefit concerns JPMorgan cut Chewy to Neutral and lowered its price target to $24, warning that a one-time tariff benefit may have flattered earnings. The stock fell 11% as investors worried the profit beat wasn't sustainable.

    This is the latest analyst reaction that explains why the stock dropped even after good results.

Q2 2026
▲2▼2

Chewy cuts sales outlook, buys vet chain, but analysts see margin upside

  • Chewy cuts full-year sales outlook Chewy lowered its fiscal 2026 net sales guidance to $13.40–$13.55 billion from $13.6–$13.75 billion, citing cautious consumer spending and weaker premiumization. This directly reduces expected future revenue, pushing the stock down and making it look cheap on sales.

    This is the main negative force this period, explaining why the stock hit a five-year low valuation.

  • Chewy acquires Modern Animal vet clinics Chewy is buying Modern Animal, a tech-enabled vet care provider, adding about $70 million in 2026 revenue and up to $290 million at steady state. This expands into higher-margin pet healthcare, but integration costs will slightly drag margins this year.

    This is a new strategic move that shifts Chewy into healthcare services, a key growth driver.

  • Analysts back margin-improvement story Major banks like Goldman Sachs and Citi reiterated positive views after strong Q1 EBITDA, pointing to advertising, AI efficiency, and healthcare as margin levers. A fair value estimate of $39.85 implies big upside, though cautious guidance and insider selling temper enthusiasm.

    This shows a shift in analyst sentiment that could support the stock price despite weak sales guidance.

  • Fed rate stance pressures e-commerce The Fed held rates steady and signaled a possible hike, raising funding costs for buy-now-pay-later and consumer credit. A stronger dollar also hurts international revenue. This macro headwind pushed Chewy and other online retailers down.

    This is a new monetary policy development that directly affects Chewy's cost of doing business and consumer spending.

June 2026
▲2▼2

Chewy cuts sales outlook, buys vet chain, but analysts see margin upside

  • Chewy cuts full-year sales outlook Chewy lowered its fiscal 2026 net sales guidance to $13.40–$13.55 billion from $13.6–$13.75 billion, citing cautious consumer spending and weaker premiumization. This directly reduces expected future revenue, pushing the stock down and making it look cheap on sales.

    This is the main negative force this period, explaining why the stock hit a five-year low valuation.

  • Chewy acquires Modern Animal vet clinics Chewy is buying Modern Animal, a tech-enabled vet care provider, adding about $70 million in 2026 revenue and up to $290 million at steady state. This expands into higher-margin pet healthcare, but integration costs will slightly drag margins this year.

    This is a new strategic move that shifts Chewy into healthcare services, a key growth driver.

  • Analysts back margin-improvement story Major banks like Goldman Sachs and Citi reiterated positive views after strong Q1 EBITDA, pointing to advertising, AI efficiency, and healthcare as margin levers. A fair value estimate of $39.85 implies big upside, though cautious guidance and insider selling temper enthusiasm.

    This shows a shift in analyst sentiment that could support the stock price despite weak sales guidance.

  • Fed rate stance pressures e-commerce The Fed held rates steady and signaled a possible hike, raising funding costs for buy-now-pay-later and consumer credit. A stronger dollar also hurts international revenue. This macro headwind pushed Chewy and other online retailers down.

    This is a new monetary policy development that directly affects Chewy's cost of doing business and consumer spending.

▲2▼2

Chewy cuts sales outlook, buys vet chain, but analysts see margin upside

  • Chewy cuts full-year sales outlook Chewy lowered its fiscal 2026 net sales guidance to $13.40–$13.55 billion from $13.6–$13.75 billion, citing cautious consumer spending and weaker premiumization. This directly reduces expected future revenue, pushing the stock down and making it look cheap on sales.

    This is the main negative force this period, explaining why the stock hit a five-year low valuation.

  • Chewy acquires Modern Animal vet clinics Chewy is buying Modern Animal, a tech-enabled vet care provider, adding about $70 million in 2026 revenue and up to $290 million at steady state. This expands into higher-margin pet healthcare, but integration costs will slightly drag margins this year.

    This is a new strategic move that shifts Chewy into healthcare services, a key growth driver.

  • Analysts back margin-improvement story Major banks like Goldman Sachs and Citi reiterated positive views after strong Q1 EBITDA, pointing to advertising, AI efficiency, and healthcare as margin levers. A fair value estimate of $39.85 implies big upside, though cautious guidance and insider selling temper enthusiasm.

    This shows a shift in analyst sentiment that could support the stock price despite weak sales guidance.

  • Fed rate stance pressures e-commerce The Fed held rates steady and signaled a possible hike, raising funding costs for buy-now-pay-later and consumer credit. A stronger dollar also hurts international revenue. This macro headwind pushed Chewy and other online retailers down.

    This is a new monetary policy development that directly affects Chewy's cost of doing business and consumer spending.

© 2026 MarketDXWhy